CALCITRIOL

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C27H44O3
Molecular Weight	416.6365
Optical Activity	UNSPECIFIED
Defined Stereocenters	6 / 6
E/Z Centers	2
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C

InChI

InChIKey=GMRQFYUYWCNGIN-NKMMMXOESA-N

InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C27H44O3
Molecular Weight	416.6365
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	6 / 6
E/Z Centers	2
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/mesh/68002117 | https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/021068a_phrmr_P1.pdfhttp://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf
Curator's Comment: description was created based on several sources, including: https://www.drugs.com/cdi/calcitriol.html http://www.wikidoc.org/index.php/Calcitriol_(oral)

Calcitriol is vitamin D3. Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body. Calcitriol is used to treat hyperparathyroidism (overactive parathyroid glands) and metabolic bone disease in people who have chronic kidney failure and are not receiving dialysis. Calcitriol is also used to treat calcium deficiency (hypocalcemia). The early signs and symptoms of vitamin D intoxication associated with hypercalcemia include: weakness, headache, somnolence, nausea, vomiting, dry mouth, constipation, muscle pain, bone pain and metallic taste. Cholestyramine has been reported to reduce intestinal absorption of fatsoluble vitamins; as such it may impair intestinal absorption of Calcitriol. Ketoconazole may inhibit both synthetic and catabolic enzymes of calcitriol.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Potency
Vitamin D3 receptor 9 Target ID: P11473 Gene ID: 7421.0 Gene Symbol: VDR Target Organism: Homo sapiens (Human) Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/10517670	Binding Agent 1076	0.22 nM [Kd]
Cytochrome P450 24A1 6 Target ID: CHEMBL4521 Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/16207822 Ahn, J. et al. (2016) 'Vitamin D Hormone', p.327 Retrieved from \| https://books.google.ru/books?id=-OSECgAAQBAJ	Substrate 661
Cytochrome P450 3A4 127 Target ID: CHEMBL340 Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/16207822	Substrate 661

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2596
Secondary hyperparathyroidism 9 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf	Primary	Approved 8583	ROCALTROL Approved Use Predialysis Patients Calcitriol Capsules are indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥100 pg/mL is strongly suggestive of secondary hyperparathyroidism. Dialysis Patients Calcitriol Capsules are indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization. Hypoparathyroidism Patients Calcitriol Capsules are also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism. Launch Date 1978
Hypocalcemia 73 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf	Preventing	Approved 8583	ROCALTROL Approved Use Predialysis Patients Calcitriol Capsules are indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥100 pg/mL is strongly suggestive of secondary hyperparathyroidism. Dialysis Patients Calcitriol Capsules are indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization. Hypoparathyroidism Patients Calcitriol Capsules are also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism. Launch Date 1978
Mild to moderate plaque psoriasis 4 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022087lbl.pdf	Primary	Approved 8583	VECTICAL Approved Use VECTICAL Ointment is indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older. Launch Date 1978

C_max

Value	Dose	Co-administered	Analyte	Population
73.18 pg/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	2 mg/cm² 2 times / day multiple, topical dose: 2 mg/cm² route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
75.74 pg/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	2 mg/cm² single, topical dose: 2 mg/cm² route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
1100 pg/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

AUC

Value	Dose	Co-administered	Analyte	Population
549.29 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	2 mg/cm² 2 times / day multiple, topical dose: 2 mg/cm² route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
737.74 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	2 mg/cm² 2 times / day multiple, topical dose: 2 mg/cm² route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
575.12 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	2 mg/cm² single, topical dose: 2 mg/cm² route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
764.74 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	2 mg/cm² single, topical dose: 2 mg/cm² route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
8100 pg × h/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
25 h EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

Sourcing

Vendor/Aggregator	ID	URL
abcr GmbH	AB465093	http://www.abcr.com/shop/en/AB465093
AbMole Bioscience	M2174	http://www.abmole.com/products/calcitriol.html
Achemo Scientific Limited	AC-16679	http://www.achemo.com/search/?Keyword= 32222-06-3
Achemtek	0101-001973	http://www.achemtek.com/32222-06-3
AHH Chemical co.,ltd	NP-1040	http://www.ahhchemical.com/product/NP-1040.html
Alfa Chemistry	32222-06-3	https://www.alfa-chemistry.com/calcitriol-cas-32222-06-3-item-291485.htm
Alfa Chemistry	AP32222063-A	https://reagents.alfa-chemistry.com/product/1-25-dihydroxyvitamin-d3-solution-cas-32222-06-3-9955.html
Alfa Chemistry	AP32222063-B	https://reagents.alfa-chemistry.com/product/calcitriol-solution-cas-32222-06-3-9956.html
Alfa Chemistry	AP32222063-C	https://reagents.alfa-chemistry.com/product/1-25-dihydroxyvitamin-d3-cas-32222-06-3-9957.html
Alsachim	1921	http://www.alsachim.com/product-C2847-glo.bal-view.html
ApexBio Technology	B2141	http://www.apexbt.com/calcitriol.html
Aurora Fine Chemicals LLC	A17.877.497	http://online.aurorafinechemicals.com/info?ID=A17.877.497
Aurora Fine Chemicals LLC	K02.111.135	http://online.aurorafinechemicals.com/info?ID=K02.111.135
Aurum Pharmatech LLC	W-5161	http://www.Aurumpharmatech.com/Product/ProductDetails/W_5161
AvaChem Scientific	2191	http://www.avachem.com/productSearch.asp?2191
BioCrick	BCC4950	http://www.biocrick.com/Calcitriol-BCC4950.html
BLD Pharm	BD01358017	http://www.bldpharm.com/products/1000873-74-4.html
Boerchem	BC208534	http://www.boerchem.com/?product_35283.html
Calbiochem	679101	http://www.emdbiosciences.com/product/679101
Capot Chemical	18818	http://www.capotchem.com/en/18818.htm
Capot Chemical	19327	http://www.capotchem.com/en/19327.htm
Capot Chemical	PubChem18818	http://www.capotchem.com/en/18818.htm
Capot Chemical	PubChem19327	http://www.capotchem.com/en/19327.htm
Chem Scene	CS-0388	http://www.chemscene.com/32222-06-3.html
ChemMol	30104349	http://www.chemmol.com/chemmol/30104349.html
ChemMol	44003293	http://www.chemmol.com/chemmol/44003293.html
ChemMol	49408407	http://www.chemmol.com/chemmol/49408407.html
ChemMol	99070257	http://www.chemmol.com/chemmol/99070257.html
Chemspace	CSSB00020610488	https://chem-space.com/CSSB00020610488
Chiralblock Biosciences	CB11406	http://www.chiralblock.com/products/32222-06-3.html
Clearsynth	CS-O-06153	https://www.clearsynth.com/en/CSO06153.html
EMD Millipore	679101	http://www.emdbiosciences.com/product/679101
eNovation Chemicals	D371145	http://www.enovationchem.com/productDetails.asp?productID=D371145
eNovation Chemicals	Y0974280	https://www.enovationchem.com/ProductDetails.asp?ProductID=Y0974280
Excenen	EX-A4435	https://www.excenen.com/searchresultlist.php?id=EX-A4435
Glentham Life Sciences	GP9482	http://www.glentham.com/products/product/GP9482/
Hello Bio	HB3962	http://www.hellobio.com/luteolin-5897.html
iChemical	EBD646297	http://www.ichemical.com/products/32222-06-3.html?utm_source=PubChem&utm_medium=website&utm_campaign=product%20catalogs
Lab Network	LN01276594	https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN01276594
LGC Standards	DRE-A10934950AL-100	https://www.lgcstandards.com/US/en/p/DRE-A10934950AL-100
LGC Standards	DRE-C10934950	https://www.lgcstandards.com/US/en/p/DRE-C10934950
LGC Standards	MM0205.00	https://www.lgcstandards.com/US/en/p/MM0205.00
Matrix Scientific	144307	https://www.matrixscientific.com/144307.html
MedChem Express	HY-10002	https://www.medchemexpress.com/Calcitriol.html
MuseChem	A000862	https://www.musechem.com/product/A000862.html
OChem	1562	http://www.ocheminc.com/index.php?act=psearch&pid=222C063
Parchem	28433	http://www.parchem.com/chemical-supplier-distributor/Calcitriol-018433.aspx
Selleck Chemicals	S1466	http://www.selleckchem.com/products/Calcitriol-(Rocaltrol).html
Sigma-Aldrich	17936_SIGMA	https://www.sigmaaldrich.com/catalog/product/sigma/17936?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	C0225000_SIAL	https://www.sigmaaldrich.com/catalog/product/sial/c0225000?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	D1530_SIGMA	https://www.sigmaaldrich.com/catalog/product/sigma/d1530?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Smolecule	S800501	https://www.smolecule.com/products/s800501
Sun-shine Chemical	Calcitriol	http://sun-shinechem.com/
TCI (Tokyo Chemical Industry)	C3078	http://www.tcichemicals.com/eshop/en/us/commodity/C3078/index.html
Tocris	2551	https://www.tocris.com/products/calcitriol_2551
VladaChem	VL266434-2.5mg	https://www.vladachem.com/product.php?products=32222-06-3
Yuhao Chemical	LT7054	http://www.chemyuhao.com/32222-06-3.html

PubMed

Title	Date	PubMed
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.	2005-09-01	15754350
Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells.	2005-06	15671080
5alpha-dihydrotestosterone inhibits 1alpha,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells.	2005-05-15	15538745
Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats.	2005-05	15788476
Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.	2005-04-01	15578590
Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.	2005-04	15781002
Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.	2005-04	15728789
Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.	2005-03	15746989
Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.	2005-03	15698453
Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation.	2005-02-04	15509566
1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.	2005-02	15647825
Human bladder as a novel target for vitamin D receptor ligands.	2005-02	15572423
Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.	2005-01-31	15664452
Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo.	2005-01-28	15531762
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.	2005-01	15489543
Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation.	2005-01	15471965
Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target.	2004-12-30	15615532
Calcitriol-induced prostate-derived factor: autocrine control of prostate cancer cell growth.	2004-12-20	15386353
The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific.	2004-11-05	15331595
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.	2004-10-27	15502727
Role of uncoupling protein 2 (UCP2) expression and 1alpha, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis.	2004-09	15231722
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts.	2004-08	15268896
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.	2004-08	15264182
Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.	2004-07-08	15138306
Differential regulation of osteogenic marker gene expression by Wnt-3a in embryonic mesenchymal multipotential progenitor cells.	2004-06	15270777
Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.	2004-05	15354979
DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line.	2004-04-13	14996990
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.	2004-03	15040831
1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2).	2004-03	15036392
Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and -24-hydroxylase in leptin-deficient, ob/ob mice.	2004-03	14657008
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.	2004-02	14966565
Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells.	2004-01-01	14729647
Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals.	2004-01	14525957
Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.	2003-11-21	12954644
Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity.	2003-09-12	12829710
9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells.	2003-08-15	12898515
Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis.	2003-08-15	12875902
Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.	2003-08	14503802
Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats.	2003-08	12846736
Vitamin D enhances mitogenesis mediated by keratinocyte growth factor receptor in keratinocytes.	2003-06-01	12761878
1alpha,25(OH)2D3 causes a rapid increase in phosphatidylinositol-specific PLC-beta activity via phospholipase A2-dependent production of lysophospholipid.	2003-05	12798493
Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.	2003-05	12798352
Regulation of 1-alpha, 25-dihydroxyvitamin D3 on interleukin-6 and interleukin-8 induced by sulfur mustard (HD) on human skin cells.	2003-05	12753408
Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis.	2003-04	12709817
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.	2003-04	12631365
EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.	1992-12-15	1472092
Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3.	1992-12-01	1450407
Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture.	1992-12	1476184
A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.	1992-09	1517380
Effect of 1,25-dihydroxyvitamin D3 on the female reproductive system in rats.	1992-08	1453499

Patents

Sample Use Guides

In Vivo Use Guide

Mice: Trans-calcitriol at 1.0, 2.0, and 4.0 mg/kg did not elicit any clinical effects after a single oral dose followed by 14 days of observation.

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:09:10 GMT 2025` Edited by `admin` on `Mon Mar 31 18:09:10 GMT 2025`
Record UNII	FXC9231JVH
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CALCITRIOL

Official Name

English

CALCIJEX

Preferred Name

English

CALCITRIOL [MART.]

Common Name

English

VECTICAL

Brand Name

English

CALCITRIOL [VANDF]

Common Name

English

ROCALTROL

Brand Name

English

CALCITRIOL [USP MONOGRAPH]

Common Name

English

CALCITRIOL [EP MONOGRAPH]

Common Name

English

(1S,3R,5Z,7E)-9,10-SECOCHOLESTA-5,7,10-TRIENE-1,3,25-TRIOL

Common Name

English

CALCITRIOL [USP-RS]

Common Name

English

RO-21-5535

Code

English

CALCITRIOL [JAN]

Common Name

English

RO-215535

Code

English

Calcitriol [WHO-DD]

Common Name

English

CALCITRIOL [HSDB]

Common Name

English

CALCITRIOL [ORANGE BOOK]

Common Name

English

calcitriol [INN]

Common Name

English

1,25-DIHYDROXY VITAMIN D3

Common Name

English

1,25-HYDROXYLATED VITAMIN D

Common Name

English

1,25-DIHYDROXYVITAMIN D3

Common Name

English

RO 21-5535

Code

English

CALCITRIOL [USAN]

Common Name

English

CALCITRIOL [MI]

Common Name

English

9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, (1.ALPHA.,3.BETA.,5Z,7E)-

Common Name

English

(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1?,3?,25-triol

Common Name

English

1,25-DIHYDROXYCHOLECALCIFEROL, (1ALPHA)-

Common Name

English

Classification Tree Code System Code

NDF-RT

N0000006996